Features
Latest World Pharmaceuticals Feature
Outsource and intake For decades, pharmaceutical companies have relied on contract development and manufacturing companies (CDMOs) to develop drugs. But though these third-party contractors proved their...
Double agents Looking at a vial of liquid or a solid pill, it’s easy to see pharmaceuticals as simple objects rather than a complex array of chemicals and raw materials, delicately balanced to...
The struggle to supply Pharmaceutical supply chains are still reacting to the pressures of the pandemic, though they have mostly held steady and avoided many of the potential risks. The stresses placed...
Good things, small packages Containers have been an inescapable part of the pharma supply chain forever – but it’s only with the rise of sophisticated new treatments, and the consequences of the pandemic,...
A glass act Glass has been the most popular primary packaging choice for drug makers for centuries, a combination of its formulation compatibility and low permeability. But the choice of...
Better sterile than sorry Sterility throughout the manufacturing process is something no pharmaceutical company can overlook, both from a regulatory and a customer care standpoint. That said, the actual...
The digital health game Some of the most ground-breaking results come when technologies are combined with the same ambition in mind. Advances in pharmaceuticals will continue to change people’s lives,...
Down the hatch Vaccination continues to be our best defence against the morbidity and mortality caused by Covid-19, but with the imperative to ‘boost’ the number of antibodies by giving multiple...
Subject to requirements Clinical trial materials each have unique packaging requirements, and there are also a number of processes and systems to consider that can help to minimise delays and ensure a...
Choosing the right central lab Central laboratories have become an important part of running global clinical trials in Europe and the US. With the rapid increase in the number of studies conducted in China and...
Rise to the challenge Running a clinical trial can be a difficult process at the best of times, but the level of complexity can be orders of magnitude higher when it comes to rare disease research....
Clinical trials and tribulations Even though they’re often a vital conduit between the drug and patient, ancillary supplies are sometimes seen as an afterthought for sponsors, who have been known to request items at...
Cash in on opportunity Adaptive trial designs have enabled clinical research to keep up with Covid-19, but their operational costs and complexities might be harder to justify once the pandemic has passed...
Trial at home Clinical trials have historically been done at hospitals or clinics, with subjects and researchers convening to get results. But with the rise of new technology – to say nothing of...
Next-gen vaccines The lockdowns of 2020 and beyond led to economic disruption on a scale not seen outside of wartime, and the imperative to reduce some of this damage led to the fastest vaccines...
Reap the benefits Clinical study protocols are important cornerstones on the journey of collecting the clinical data needed to elucidate the benefit-risk profile of medical treatments/devices....
The smart money Smart packaging offers huge value to the whole of the supply chain. There are a number of recent innovations that can help optimise monitoring. Louise Thomas speaks to Ruud van der...
Counterfeit and proper The health crisis created by Covid-19 has created further opportunities for black market medicines to be sold to worried populations. Jackie Pullman explores how Novartis, through...
Waste not, want not The health sector is responsible for an estimated 4.4% of global greenhouse gas emissions – the vast majority of which originate in the supply chain. One of the easiest ways to...
View all features A-Z
